ask="9.99"
ask_size="100"
average_daily_volume="34648"
bid="2.82"
bid_size="100"
book_value="0.49"
change="-0.23"
change_from_200_day_moving_average="-0.57"
change_from_50_day_moving_average="-0.47"
change_from_52_week_high="-5.83"
change_From_52_week_low="0.36"
change_in_percent="-6.76%"
close="3.17"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.42"
ebitda="-15.65M"
eps_estimate_current_year="-1.62"
eps_estimate_next_quarter="-0.36"
eps_estimate_next_year="-1.49"
ex_dividend_date="N/A"
float_shares="5060000"
high="3.29"
high_52_weeks="9.00"
last_trade_date="1/23/2017"
last_trade_price="3.17"
last_trade_size="100"
last_trade_time="4:00pm"
low="3.14"
low_52_weeks="2.81"
market_capitalization="26.56M"
moving_average_200_day="3.74"
moving_average_50_day="3.64"
name="VistaGen Therapeutics
Inc."
notes="N/A"
one_year_target_price="23.50"
open="3.26"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="-15.13%"
percent_change_from_50_day_moving_average="-12.90%"
percent_change_from_52_week_high="-64.78%"
percent_change_from_52_week_low="+12.81%"
previous_close="3.40"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="6.88"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="8379000"
short_ratio="2.72"
stock_exchange="NCM"
symbol="VTGN"
volume="55013"
weeks_range_52="2.81 - 9.00"
